Efficacy and Safety of Zavegepant Nasal Spray for the Acute Treatment of Migraine: Results of a Phase 3 Double-Blind, Randomized, Placebo Controlled Trial

被引：0

作者：

Mullin, K. ^{[1
]}

Croop, R. ^{[2
]}

Pavlovic, J. ^{[3
]}

Mosher, L. ^{[2
]}

Smith, T. ^{[4
]}

Madonia, J. ^{[2
]}

Lovegren, M. ^{[2
]}

Coric, V. ^{[2
]}

Lipton, R. ^{[3
]}

机构：

[1] New England Inst Neurol & Headache, Stamford, CT USA

[2] Biohaven Pharmaceut, New Haven, CT USA

[3] Albert Einstein Coll Med, Bronx, NY 10467 USA

[4] Study Metrix Res, St Peters, MO USA

来源：

JOURNAL OF HEADACHE AND PAIN | 2022年 / 23卷 / SUPPL 1期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P136a

引用

页数：2

共 50 条

[41] Efficacy and Safety of AXS-07 (MoSEIC™ Meloxicam/Rizatriptan) in the Acute Treatment of Migraine: Results from the MOMENTUM Phase 3, Randomized, Double-Blind, Active- and Placebo-Controlled Trial
O'Gorman, Cedric
Jones, Amanda
Lipton, Richard B.
Tepper, Stewart J.
Tabuteau, Herriot
ANNALS OF NEUROLOGY, 2020, 88 : S152 - S152
[42] Efficacy, safety, and tolerability of rimegepant 75 mg orally dissolving tablet for the acute treatment of migraine: Results from a phase 3, double-blind, randomized, placebo-controlled trial, Study 303
Lipton, Richard B.
Coric, Vladimir
Stock, Elyse
Stock, David
Thiry, Alexandra
Conway, Charles
Dubowchik, Gene
Jensen, Christopher
Gosden, Ralph
Frost, Marianne
Gentile, Kimberly
Morris, Beth
Forshaw, Micaela
Croop, Robert
NEUROLOGY, 2019, 93 (05) : E532 - E532
[43] Results of the double-blind, randomized, placebo controlled, phase 2 safety and efficacy trial of MULTISTEM® in adults with ischemic stroke
Hess, D. C.
Clark, W. D.
Chiu, D.
Wechsler, L. R.
Uchino, K.
Auchus, A. P.
Sila, C. A.
Furlan, A. J.
Switzer, J. A.
Mays, R. W.
INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 8 - 8
[44] Efficacy of phenazone in the treatment of acute migraine attacks:: a double-blind, placebo-controlled, randomized study
Göbel, H
Heinze, A
Niederberger, U
Witt, T
Zumbroich, V
CEPHALALGIA, 2004, 24 (10) : 888 - 893
[45] Efficacy and Safety of Chuanxiong Qingnao Granule in Patients with Migraine: A Randomized, Double-Blind, Placebo-Controlled Trial
Li, Yi-Fan
Hu, Hui-Min
Wang, Bo-Ning
Zhang, Yi
Liu, Xing
Mao, Peng
Fan, Bi-Fa
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
[46] Efficacy and Safety of Toutongning Capsule in Patients with Migraine: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Yu, Shengyuan
Ran, Ye
Wan, Qi
Yang, Xiaosu
Chen, Huisheng
Wang, Hebo
Hu, Xueqiang
Mao, Shanping
Yu, Tingming
Luo, Guogang
Guan, Yangtai
Gao, Xuguang
Li, Xin
Zhou, Muke
Li, Yu
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2019, 25 (12) : 1215 - 1224
[47] Efficacy and safety of acetaminophen in the treatment of migraine -: Results of a randomized, double-blind, placebo-controlled, population-based study
Lipton, RB
Baggish, JS
Stewart, WF
Codispoti, JR
Fu, M
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (22) : 3486 - 3492
[48] EFFICACY OF A NICOTINE NASAL SPRAY IN SMOKING CESSATION - A PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL
SCHNEIDER, NG
OLMSTEAD, R
MODY, FV
DOAN, K
FRANZON, M
JARVIK, ME
STEINBERG, C
ADDICTION, 1995, 90 (12) : 1671 - 1682
[49] Efficacy and safety of avanafil for the treatment of erectile dysfunction: Results of a multicenter, randomized, double-blind, placebo-controlled trial
Park, J. K.
Zhao, C.
Kim, S. W.
Yang, D. Y.
Kim, J. J.
Park, N. C.
Lee, S. W.
Paick, J. S.
Ahn, T. Y.
Moon, K. H.
Chung, W. S.
Min, K. S.
Suh, J. K.
Hyun, J. S.
Park, K.
EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E701 - U494
[50] Efficacy and Safety of Sublingual Cyclobenzaprine for the Treatment of Fibromyalgia: Results From a Randomized, Double-Blind, Placebo-Controlled Trial
Lederman, Seth
Arnold, Lesley M.
Vaughn, Ben
Kelley, Mary
Sullivan, Gregory M.
ARTHRITIS CARE & RESEARCH, 2023, 75 (11) : 2359 - 2368

← 1 2 3 4 5 →